Drug
Racemic Albuterol
Racemic Albuterol: highest development phase Post-Market, developed by Sumitomo Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Sumitomo Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Racemic albuterol (R+S albuterol) NCT00124176 | Post-Market | Asthma |
Latest
No recent events.
Follow Racemic Albuterol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.